Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder
Authors
Keywords
-
Journal
EXPERIMENTAL AND MOLECULAR PATHOLOGY
Volume 131, Issue -, Pages 104860
Publisher
Elsevier BV
Online
2023-04-14
DOI
10.1016/j.yexmp.2023.104860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers
- (2022) David Dum et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
- (2022) Keisuke Shigeta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer
- (2022) Camilla De Carlo et al. Cancers
- GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder
- (2022) Henning Plage et al. HUMAN PATHOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer
- (2021) Tim Muilwijk et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Association of current molecular subtypes in urothelial carcinoma with patterns of muscularis propria invasion
- (2021) Koorosh Haghayeghi et al. VIRCHOWS ARCHIV
- A single–cell type transcriptomics map of human tissues
- (2021) Max Karlsson et al. Science Advances
- Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer
- (2021) Tanan Bejrananda et al. Scientific Reports
- Assessment of Luminal and Basal Phenotypes in Bladder Cancer
- (2020) Charles C. Guo et al. Scientific Reports
- Urothelial Carcinoma In Situ of the Bladder
- (2020) Kara A. Lombardo et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review
- (2019) Francesca Sanguedolce et al. PATHOLOGY RESEARCH AND PRACTICE
- Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder
- (2019) Maria Del Carmen Rodriguez Pena et al. VIRCHOWS ARCHIV
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20
- (2019) Hemlata Jangir et al. Annals of Diagnostic Pathology
- Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications
- (2018) Isabella Barth et al. VIRCHOWS ARCHIV
- Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma
- (2018) Minsun Jung et al. HISTOPATHOLOGY
- Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
- (2017) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- A proposal for validation of antibodies
- (2016) Mathias Uhlen et al. NATURE METHODS
- Update of the FANTOM web resource: high resolution transcriptome of diverse cell types in mammals
- (2016) Marina Lizio et al. NUCLEIC ACIDS RESEARCH
- Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
- (2016) Vipulkumar Dadhania et al. EBioMedicine
- Gateways to the FANTOM5 promoter level mammalian expression atlas
- (2015) Marina Lizio et al. GENOME BIOLOGY
- Dedifferentiation and reprogramming: origins of cancer stem cells
- (2014) D. Friedmann-Morvinski et al. EMBO REPORTS
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases
- (2012) Esther Oliva et al. HUMAN PATHOLOGY
- When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression
- (2011) David J. DeGraff et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Molecular pathways of urothelial development and bladder tumorigenesis
- (2010) Mireia Castillo-Martin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Diagnostic algorithm for papillary urothelial tumors in the urinary bladder
- (2008) Jung-Weon Shim et al. VIRCHOWS ARCHIV
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started